A detailed history of Xtx Topco LTD transactions in I Mab stock. As of the latest transaction made, Xtx Topco LTD holds 43,039 shares of IMAB stock, worth $41,747. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,039
Previous 17,876 140.76%
Holding current value
$41,747
Previous $29,000 82.76%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.03 - $1.72 $25,917 - $43,280
25,163 Added 140.76%
43,039 $53,000
Q2 2024

Aug 12, 2024

SELL
$1.58 - $1.9 $19,922 - $23,957
-12,609 Reduced 41.36%
17,876 $29,000
Q1 2024

May 13, 2024

SELL
$1.54 - $2.37 $8,417 - $12,954
-5,466 Reduced 15.2%
30,485 $56,000
Q4 2023

Feb 13, 2024

BUY
$1.21 - $1.9 $43,500 - $68,306
35,951 New
35,951 $68,000
Q1 2023

May 12, 2023

BUY
$3.08 - $7.39 $32,583 - $78,178
10,579 New
10,579 $36,000

Others Institutions Holding IMAB

About I-Mab


  • Ticker IMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,098,800
  • Market Cap $80.6M
  • Description
  • I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...
More about IMAB
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.